Alpha Tau Medical Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	4.64	12.2	13.72	12.66	5.84	23.24
Short-Term Investments	71.78	60.92	45.88	69.13	98.69	8.08
Cash & Short-Term Investments	76.42	73.13	59.6	81.79	104.53	31.32
Cash Growth	48.00%	22.70%	-27.13%	-21.76%	233.79%	-31.94%
Other Current Assets	4.93	5.17	4.63	3.97	1.95	1.33
Total Current Assets	81.35	78.3	64.23	85.76	106.48	32.64
Net Property, Plant & Equipment	26.96	26.88	21.54	21.16	13.28	7.55
Other Long-Term Assets	0.46	0.48	0.43	0.47	0.39	2.03
Total Assets	108.77	105.65	86.2	107.39	120.15	42.22
Accounts Payable	3.72	3.87	3.53	2.57	1.42	1.2
Accrued Expenses	5.53	5.51	4.13	3.47	2.25	3.2
Current Portion of Leases	1.2	1.13	1.01	1.06	0.67	-
Total Current Liabilities	10.45	10.51	8.68	7.1	4.34	4.41
Long-Term Debt	6.4	6.35	5.56	5.61	-	-
Long-Term Leases	6.74	6.24	5.96	6.6	4.52	-
Other Long-Term Liabilities	15.83	5.45	3.34	3.6	5.63	18.62
Total Long-Term Liabilities	28.97	18.05	14.86	15.81	10.15	18.62
Total Liabilities	39.42	28.55	23.54	22.91	14.49	23.03
Minority Interest	-	-	-	-	-	53.96
Shareholders' Equity	69.35	77.1	62.67	84.48	105.66	19.19
Total Liabilities & Equity	108.77	105.65	86.2	107.39	120.15	42.22
Total Debt	14.34	13.73	12.54	13.28	5.19	0
Net Cash (Debt)	62.08	59.4	47.06	68.51	99.34	31.32
Net Cash Growth	4.51%	26.21%	-31.30%	-31.03%	217.21%	-31.94%
Net Cash Per Share	0.73	0.74	0.67	0.99	1.56	0.77

SEC Filings: 10-K · 10-Q